PWLP
REGN icon

Prio Wealth Limited Partnership’s Regeneron Pharmaceuticals REGN Stock Holding History

Prio Wealth Limited Partnership’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$210K Hold
200
– – 0.01% 259
2024
Q2 		$210K Buy
+200
New +$194K 0.01% 250

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Prio Wealth Limited Partnership's REGN Position: Q3 2024 in Review

Prio Wealth Limited Partnership held its Regeneron Pharmaceuticals (REGN) position steady in Q3 2024 at 200 shares worth $210K. The position accounts for 0.01% of the portfolio, ranked #259.

Prio Wealth Limited Partnership first reported a position in REGN in Q2 2024 and has held it in 2 quarters since. 1,388 funds tracked by Wall St. Rank hold REGN as of Q3 2024.

  • Prio Wealth Limited Partnership held 200 shares of Regeneron Pharmaceuticals worth $210K as of Q3 2024.
  • Prio Wealth Limited Partnership left its Regeneron Pharmaceuticals share count unchanged in Q3 2024.
  • Regeneron Pharmaceuticals made up 0.01% of Prio Wealth Limited Partnership's portfolio in Q3 2024, its #259 holding.
  • Prio Wealth Limited Partnership first reported a position in Regeneron Pharmaceuticals in Q2 2024 and has held it in 2 quarters since.
  • 1,388 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2024.

Based on Prio Wealth Limited Partnership's 13F filing for Q3 2024, filed 21 Oct 2024.